The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of perioperative cisplatin/gemcitabine (cis/gem) and durvalumab (durva) for operable muscle-invasive urothelial carcinoma (MIUC): SAKK 06/17.
Richard Cathomas
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Debiopharm Group; Janssen-Cilag
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology; Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Sacha Rothschild
Honoraria - AstraZeneca (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche; Takeda (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst); Takeda (Inst)
Stefanie Hayoz
No Relationships to Disclose
Martin Spahn
No Relationships to Disclose
Julian Schardt
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Roland Seiler
No Relationships to Disclose
Andreas Erdmann
No Relationships to Disclose
Stefanie Aeppli
Consulting or Advisory Role - Genzyme (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen
Nicolas Mach
Stock and Other Ownership Interests - MaxiVax
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche
Research Funding - MaxiVax (Inst)
Patents, Royalties, Other Intellectual Property - MaxiVax (Inst)
Raeto Strebel
Honoraria - Janssen-Cilag
Boris A. Hadaschik
Consulting or Advisory Role - ABX Advanced biochemical compounds; Bayer; Janssen; Lightpoint medical
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen
Dominik R. Berthold
Consulting or Advisory Role - Astellas Oncology; Janssen; Pfizer; Roche
Miklos Pless
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Janssen
Travel, Accommodations, Expenses - AstraZeneca; BMI; Boehringer Ingelheim; Vifor Pharma
Deborah Zihler
Consulting or Advisory Role - Amgen; BMSi; Novartis; Pierre Fabre; Roche; Sanofi
Mathias Schmid
No Relationships to Disclose
Martina Schneider
No Relationships to Disclose
Zuzanna Maniecka
No Relationships to Disclose
Ulf Petrausch
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Janssen